With a dedicated product theater and new real-world evidence posters, Theranica will spotlight how the Nerivio® REN wearable is reshaping...
INDIANAPOLIS, Oct. 8, 2025 /PRNewswire/ -- Momentum Life Sciences announces the winners of the premier Patient Support Awards, known as...
Introduction of expanded coaching and advisory services coincides with 2025 American Academy of Ophthalmology Annual Meeting SAN FRANCISCO, Oct. 7,...
In this free webinar, learn how biomarkers and digital tools are improving clinical trials in neurodegenerative diseases. Attendees will understand the...
New Predictive Platform Will Use Digital Technology and AI to Assist Clinician Decision-Making BRONX, N.Y., Oct. 6, 2025 /PRNewswire/ -- Serious...
New subscription-based platform empowers a community of Swoop® system users worldwide to access advanced tools in support of imaging research...
SANTA ANA, Calif., Oct. 06, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage...
Burixafor (GPC-100) Phase 2 Trial in Multiple Myeloma Nears Key Readout Preparing for Expansion into Sickle Cell Disease and Acute...
Successful meeting with FDA enables advancement into pivotal development with Privosegtor in Acute Optic Neuritis (AON) and Non-arteritic Anterior Ischemic...
Recognized for innovation in Biostatistics, Clinical Data Management, and Real-World Evidence, powered by AI-driven platforms GAITHERSBURG, MARYLAND / ACCESS Newswire...
Coinciding with 2025 American Academy of Ophthalmology Annual Meeting, the company debuts expanded services and tools for exclusive real-world insights from 85...
Cambridge, UK, 1 October 2025 – Maxion Therapeutics (“Maxion”), a biotechnology company developing antibody-based KnotBody® drugs for ion channel and G...
The Balancing Act airing on Lifetime will showcase how innovative treatments Thermage® FLX, Clear + Brilliant®, and Fraxel FTX™ offer...
The Balancing Act airing on Lifetime will showcase how innovative treatments Thermage® FLX, Clear + Brilliant®, and Fraxel FTX™ offer...
LAVAL, QC / ACCESS Newswire / September 30, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release third quarter 2025...
Leveraging MaxYield™ ECG to capture real-world exercise data in people living with neurological conditionsGenerating actionable insights into how cardiac responses...
Publication title: “Oral Blarcamesine Phase IIb/III Trial Confirms Identified Precision Medicine Patient Population – Significant Broad Clinical and Quality of...
ROCKAWAY, N.J., Sept. 30, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today...
Designed for dental professionals, OraTalks connects leading voices with insights to spark meaningful dialogue.Nine-episode inaugural season hosted by industry thought...
SUGAR LAND, Texas, Sept. 26, 2025 /PRNewswire/ -- Deep EigenMatics, a startup developing innovative Artificial Intelligence methods for drug discovery and...